Calculate the GRACE score for acute coronary syndrome risk stratification including in-hospital and 6-month mortality prediction.
The GRACE (Global Registry of Acute Coronary Events) score is one of the most extensively validated risk stratification tools for patients presenting with acute coronary syndromes (ACS), including ST-elevation myocardial infarction (STEMI), non-ST-elevation myocardial infarction (NSTEMI), and unstable angina. Developed from a multinational registry of over 40,000 patients, the GRACE score predicts both in-hospital and 6-month mortality with excellent discriminative ability (C-statistic > 0.80).
The score integrates eight readily available clinical variables: age, heart rate, systolic blood pressure, serum creatinine, Killip class, cardiac arrest at presentation, ST-segment deviation, and elevated cardiac biomarkers. These variables capture the key pathophysiologic determinants of ACS outcomes including myocardial injury severity, hemodynamic status, renal function, and heart failure.
European Society of Cardiology (ESC) guidelines commonly reference GRACE scoring when framing risk and timing discussions in ACS. Higher scores place patients in bands where earlier invasive review is more often considered, but the score is still one input among symptoms, ECG findings, biomarker trends, instability, and clinician judgment.
The GRACE score provides structured risk stratification for acute coronary syndrome and helps estimate short-term prognosis. It is commonly used alongside ECG findings, biomarkers, and clinical assessment when framing management timing discussions.
GRACE Score = Sum of age points (0–100) + heart rate points (0–46) + systolic BP points (0–58) + creatinine points (1–28) + Killip class points (0–59) + cardiac arrest points (0 or 39) + ST deviation points (0 or 28) + elevated enzymes points (0 or 14). Total range: 1–372.
Result: GRACE Score 107 — Low Risk
A 65-year-old with HR 85, SBP 130, creatinine 1.1, Killip I, no cardiac arrest or ST deviation, but elevated enzymes scores 107, placing them in the low-risk category with < 1% in-hospital mortality.
The GRACE score was developed from the Global Registry of Acute Coronary Events, a prospective multinational registry established in 1999 across 94 hospitals in 14 countries. The original model was derived from over 40,000 patients and has been externally validated in numerous independent cohorts worldwide. The C-statistic for in-hospital mortality prediction exceeds 0.80, demonstrating excellent discriminative ability.
The ESC guidelines for the management of ACS without persistent ST-elevation recommend GRACE scoring for NSTEMI and unstable angina risk stratification. The score categorizes patients into low (≤ 108), intermediate (109–140), or high (> 140) risk groups. Higher-risk bands commonly shape how urgently invasive review is discussed, but the score remains one part of a larger ACS assessment rather than a self-contained order pathway.
The updated GRACE 2.0 model (2014) allows substitution of creatinine clearance for serum creatinine and Killip class for diuretic use, making it applicable when complete data are unavailable. The GRACE risk calculator has also been extended to predict 1-year and 3-year mortality, further enhancing its clinical utility for long-term risk communication and secondary prevention planning.
Last updated:
This worksheet calculates the GRACE score and broad ACS risk bands from the usual presentation, ECG, and lab inputs.
The GRACE score is a validated clinical tool that estimates in-hospital and 6-month mortality risk in patients with acute coronary syndromes. It was derived from an international registry of over 40,000 ACS patients across 94 hospitals.
It is most commonly calculated at ACS presentation to structure early risk stratification. It can also be revisited during hospitalization if the hemodynamic or laboratory picture changes.
A GRACE score > 140 is commonly treated as a high-risk band (> 3% in-hospital mortality, > 8% 6-month mortality). That band often pushes earlier invasive discussion, but it is not a stand-alone procedural order.
The GRACE score helps frame how teams discuss invasive versus conservative pathways. It should be read alongside symptoms, ECG findings, biomarkers, instability, and local ACS protocols.
Killip classification assesses heart failure severity in AMI: Class I (no CHF), Class II (rales, JVD, S3), Class III (pulmonary edema), and Class IV (cardiogenic shock). Higher classes carry significantly worse prognosis.
Yes, the GRACE score is validated for all ACS presentations including STEMI, NSTEMI, and unstable angina. However, STEMI patients typically proceed directly to primary PCI regardless of GRACE score.